The exodus of listed cannabis companies from the public markets, particularly in the UK, is continuing at pace as yet another medical cannabis operator has announced plans to delist.
IM Cannabis IM Cannabis saw its stock price jump by nearly 10% this week after it announced the receipt of US$500k in funding in a private placement led by two company insiders.
FOLLOWING a whirlwind year of acquisitions, fund raises and a debut on the NASDAQ stock exchange, IM Cannabis (IMC) is now entering the next phase of its lifecycle.
As you can see, we are changing some things up in 2021. Same great information and updates, but a more streamlined delivery via email.
